Understanding anti-leukemia responses to donor lymphocyte infusion

Abstract

Donor lymphocyte infusion (DLI) is an established and potentially curative immune therapy for relapsed leukemia after hematopoietic stem cell transplant (HSCT). Herein, we describe the utility of DLI as a tractable model system to glean fresh insights into understanding and predicting effective anti-leukemia immunity.

Extracted Key Phrases

0204020162017
Citations per Year

Citation Velocity: 8

Averaging 8 citations per year over the last 2 years.

Learn more about how we calculate this metric in our FAQ.

Cite this paper

@inproceedings{Bachireddy2014UnderstandingAR, title={Understanding anti-leukemia responses to donor lymphocyte infusion}, author={Pavan Bachireddy and Catherine J. Wu}, booktitle={Oncoimmunology}, year={2014} }